Stocktoria
Chugai Pharmaceutical Co., Ltd. 4519.T
Chugai Pharmaceutical Co., Ltd. statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (¥2,702.68); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Chugai Pharmaceutical Co., Ltd. trades at about 24.3× earnings — below its 10-year norm (10-year range 14.8×–33.4×, median 28.6×).
Shaded band = 10-year range (14.8×–33.4×); dot = today's 24.3×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 71.1% | 71.0% | 62.8% | 62.2% |
| Operating margin | 47.6% | 46.3% | 39.5% | 42.3% |
| Net margin | 34.5% | 33.1% | 29.3% | 29.7% |
| FCF margin | 21.8% | 33.5% | 30.2% | 13.7% |
| Return on assets | 17.6% | 17.5% | 16.8% | 20.0% |
| Return on equity | 21.4% | 20.4% | 20.0% | 26.3% |
| Current ratio | 4.23 | 5.53 | 4.74 | 3.15 |
Computed from company filings · JP · as of 2025-12-31. Figures in JPY. Facts plus Stocktoria's own computed scores — not investment advice.